Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Ranolazine on Skeletal Muscle Endpoints During Exercise In Subjects With Chronic Angina and Peripheral Arterial Disease

NCT00657514 is registered in ClinicalTrials.gov with Colorado Prevention Center as lead sponsor.

NCT NCT00657514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00657514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Ranolazine on Skeletal Muscle Endpoints During Exercise In Subjects With Chronic Angina and Peripheral Arterial Disease
Lead sponsor
Colorado Prevention Center
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2008
Completion date
June 30, 2009
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

angina, peripheral arterial disease